пятница, 27 января 2017 г.

Biogen's profit forecast lags as new CEO takes the helm

Biogen's profit forecast lags as new CEO takes the helm


Biogen Inc. forecast 2017 profit that trailed some estimates as new Chief Executive Officer Michel Vounatsos took the helm of the biotechnology company. The company sees earnings of $20.45 to $21.25 a share, excluding some items, compared with the $21.03 average of projections compiled by Bloomberg.



from Biotech News